An update on the prevention of influenza in children and adolescents

European Journal of Pediatrics

Volumn 162, Issue 12, 2003, Pages 828-836

  Heininger, Ulrich ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Immunization; Influenza; Neuraminidase inhibitors; Prevention; Review

Indexed keywords

INFLUENZA VACCINE; LIVE VACCINE; OSELTAMIVIR; SIALIDASE INHIBITOR; VIROSOME; VIRUS VACCINE; ZANAMIVIR;

ADOLESCENT; BACTERIAL INFECTION; CHILD; DRUG EFFICACY; DRUG SAFETY; EPIDEMIC; EUROPE; FEBRILE CONVULSION; FEVER; GASTROINTESTINAL SYMPTOM; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; IMMUNIZATION; INFECTION PREVENTION; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; LUNG TOXICITY; MYOSITIS; NONHUMAN; NOSE CONGESTION; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; RHINORRHEA; SUPERINFECTION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; ENZYME INHIBITORS; EUROPE; HUMANS; IMMUNIZATION; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; NEURAMINIDASE;

EID: 0346328282     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-003-1324-6     Document Type: Review

References (64)

1. Belshe RB, Van Voris LP (1984) Cold-recombinant influenza A/California/10/78 (H1N1) virus vaccine (CR-37) in seronegative children: infectivity and efficacy against investigational challenge. J Infect Dis 149: 735-740
2. Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, Bernstein DI, Hayden FG, Kotloff K, Zangwill K, Iacuzio D, Wolff M (1998) The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N Engl J Med 338: 1405-1412
3. Belshe RB, Gruber WC, Mendelman PM, Cho I, Reisinger K, Block SL, Wittes J, Iacuzio D, Piedra P, Treanor J, King J, Kotloff K, Bernstein DI, Hayden FG, Zangwill K, Yan L, Wolff M (2000) Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr 136: 168-175
4. Bernstein DI, Cherry JD (1983) Clinical reactions and antibody responses to influenza vaccines. A comparison of split or subunit vaccines in children and young adults. Am J Dis Child 137: 622-626
5. Bridges CB, Fukuda K, Uyeki TM, Cox NJ, Singleton JA (2002) Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 51(RR-3): 1-31
6. Centers for Disease Control and Prevention (2003) Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 52 (RR-8): 1-36
7. Clements ML, Makhene MK, Karron RA, Murphy BR, Steinhoff MC, Subbarao K, Wilson MH, Wright PF (1996) Effective immunization with live attenuated influenza A virus can be achieved in early infancy. J Infect Dis 173: 44-51
8. Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner D, Nicholson KG (2003) Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ 326: 1235
9. Couch RB (2000) Prevention and treatment of influenza. N Engl J Med 343: 1778-1787
10. Daubeney P, Taylor CJ, McGaw J, Brown EM, Ghosal S, Keeton BR, Palache B, Kerstens R (1997) Immunogenicity and tolerability of a trivalent influenza subunit vaccine (Influvac) in high-risk children aged 6 months to 4 years. Br J Clin Pract 51: 87-90
11. Deutsche Akademie für Kinderheilkunde und Jugendmedizin, Kommission für Infektionskrankheiten und Impfungen (Bartmann P, Heininger U, Huppertz HI, Kinet M, Korenke GC, Schick KH) (2003) Stellungnahme zur Verwendung von Neuraminidasehemmern zur Therapie bzw. Prophylaxe der Influenza bei Kindern und Jugendlichen. Monatsschr Kinderheilkd 151: 110-112
12. Edwards KM, Dupont WD, Westrich MK, Plummer WD Jr, Palmer PS, Wright PF (1994) A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis 169: 68-76
13. Glezen WP (1996) Emerging infections: pandemic influenza. Epidemiol Rev 18: 64-76
14. Glezen WP (2002) Influenza vaccination for healthy children. Curr Opin Infect Dis 15: 283-287
15. Glück R (2001) Pre-clinical and clinical investigation of the safety of a novel adjuvant for intranasal immunization. Vaccine 20[Suppl 1]: S42-S44
16. Glück R, Mischler R, Durrer P, Furer E, Lang AB, Herzog C, Cryz SJ Jr (2000) Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant. J Infect Dis 181: 1129-1132
17. Groothuis JR, Levin MJ, Rabalais GP, Meiklejohn G, Lauer BA (1991) Immunization of high-risk infants younger than 18 months of age with split-product influenza vaccine. Pediatrics 87: 823-828
18. Gruber WC, Campbell PW, Thompson JM, Reed GW, Roberts B, Wright PF (1994) Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: results of a 3-year study. J Infect Dis 169: 241-247
19. Gruber WC, Belshe RB, King JC, Treanor JJ, Piedra PA, Wright PF, Reed GW, Anderson E, Newman F (1996) Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. J Infect Dis 173: 1313-1319
20. Gubareva LV, Kaiser L, Hayden FG (2000) Influenza virus neuraminidase inhibitors. Lancet 355: 827-835
21. Hayden F, Belshe R, Villanueva C, Lanno R, Small I, Hughes C, Dutkowski R (2002). Oral oseltamivir prevents the spread of influenza between children and households (abstract). 42nd ICAAC, September 2002, San Diego, V-244
22. Hayden FG, Gubareva LV, Monto AS, Klein TC, Elliot MJ, Hammond JM, Sharp SJ, Ossi MJ (2000) Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group. N Engl J Med 343: 1282-1289
23. Heininger U, Bachler M, Schaad UB (2003) Attitudes of pediatricians regarding influenza self-immunization: a survey in a Swiss university children's hospital. Pediatr Infect Dis J 22: 391-394
24. Herzog C, Metcalfe IC, Schaad UB (2002) Virosome influenza vaccine in children. Vaccine 20[Suppl 5]: B24-B28
25. Hilleman MR (2002) Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine 20: 3068-3087
26. James JM, Zeiger RS, Lester MR, Fasano MB, Gern JE, Mansfield LE, Schwartz HJ, Sampson HA, Windom HH, Machtinger SB, Lensing S (1998) Safe administration of influenza vaccine to patients with egg allergy. J Pediatr 133: 624-628
27. Kempe A, Hall CB, MacDonald NE, Foye HR, Woodin KA, Cohen HJ, Lewis ED, Gullace M, Gala CL, Dulberg CS et al (1989) Influenza in children with cancer. J Pediatr 115: 33-39
28. Kondo S, Abe K (1991) The effects of influenza virus infection on FEV1 in asthmatic children. The time-course study. Chest 100: 1235-1238
29. Laver WG, Webster RG (1976) Preparation and immunogenicity of an influenza virus hemagglutinin and neuraminidase subunit vaccine. Virology 69: 511-522
30. Makras P, Alexiou-Daniel S, Antoniadis A, Hatzigeorgiou D (2001) Outbreak of meningococcal disease after an influenza B epidemic at a Hellenic Air Force recruit training center. Clin Infect Dis 33: e48-e50
31. Mendelman PM, Cordova J, Cho I (2001) Safety, efficacy and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults. Vaccine 19: 2221-2226
32. Mischler R, Metcalfe IC (2002) Inflexal V a trivalent virosome subunit influenza vaccine: production. Vaccine 20[Suppl 5]: B17-B23
33. Miyazaki C, Nakayama M, Tanaka Y, Kusuhara K, Okada K, Tokugawa K, Ueda K, Shibata R, Nishima S, Yamane N, Maassab HF (1993) Immunization of institutionalized asthmatic children and patients with psychomotor retardation using live attenuated cold-adapted re-assortment influenza A H1N1, H3N2 and B vaccines. Vaccine 11: 853-858
34. Monto AS, Robinson DP, Herlocher ML, Hinson JM Jr, Elliott MJ, Crisp A (1999) Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial. JAMA 282: 31-35
35. Munoz FM, Englund JA (2001) Vaccines in pregnancy. Infect Dis Clin North Am 15: 253-271
36. Neuzil KM, Dupont WD, Wright PF, Edwards KM (2001) Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J 20: 733-740
37. Neuzil KM, Zhu Y, Griffin MR, Edwards KM, Thompson JM, Tollefson SJ, Wright PF (2002) Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis 15 185: 147-152
38. O'Brien KL, Walters MI, Sellman J, Quinlisk P, Regnery H, Schwartz B, Dowell SF (2000) Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis 30: 784-789
39. Olshaker JS (2003) Influenza. Emerg Med Clin North Am 21: 353-361
40. Pachucki CT, Lentino JR, Jackson GG (1985) Attitudes and behavior of health care personnel regarding the use and efficacy of influenza vaccine. J Infect Dis 151: 1170-1171
41. Paisley JW, Bruhn FW, Lauer BA, McIntosh K (1978) Type A2 influenza viral infections in children. Am J Dis Child 132: 34-36
42. Peltola V, Ziegler T, Ruuskanen O (2003) Influenza A and B virus infections in children. Clin Infect Dis 36: 299-305
43. Pfleiderer M, Lower J, Kurth R (2001) Cold-attenuated live influenza vaccines, a risk-benefit assessment. Vaccine 20: 886-894
44. Piedra PA (1991) Influenza vaccines. Semin Pediatr Infect Dis 2: 140-146
45. Piedra PA, Yan L, Kotloff K, Zangwill K, Bernstein DI, King J, Treanor J, Munoz F, Wolff T M, Cho I, Mendelman PM, Cordova J, Belshe RB (2002) Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children. Pediatrics 110: 662-672
46. Pribble CG, Black PG, Bosso JA, Turner RB (1990) Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections. J Pediatr 117: 200-204
47. Price DA, Postlethwaite RJ, Longson M (1976) Influenza virus A2 infections presenting with febril convulsions and gastrointestinal symptoms in young children. Clin Pediatr (Phila) 15: 361-367
48. Prober CG (2002) Antiviral therapy for influenza virus infections. Semin Pediatr Infect Dis 13: 31-39
49. Rafei K (2002) Influenza virus vaccines in children and their impact on the incidence of otitis media. Semin Pediatr Infect Dis 13: 129-133
50. Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M (2001) The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 344: 889-896
51. Roldaan AC, Masural N (1982) Viral respiratory infections in asthmatic children staying in a mountain resort. Eur J Respir Dis 63: 140-150
52. Smits AJ, Hak E, Stalman WA, van Essen GA, Hoes AW, Verheij TJ (2002) Clinical effectiveness of conventional influenza vaccination in asthmatic children. Epidemiol Infect 128: 205-211
53. Stöhr K (2003) Preventing and treating influenza. BMJ 326: 1223-1224
54. Tanaka Y, Ueda K, Miyazaki C, Nakayama M, Kusuhara K, Okada K, Tokugawa K, Shibata R, Nishima S, Yamane N, Massab HF (1993) Trivalent cold recombinant influenza live vaccine in institutionalized children with bronchial asthma and patients with psychomotor retardation. Pediatr Infect Dis J 12: 600-605
55. Watanakunakorn C, Ellis G, Gemmel D (1993) Attitude of healthcare personnel regarding influenza immunization. Infect Control Hosp Epidemiol 14: 17-20
56. Webster RG, Campbell CH, Granoff A (1973) The "in vivo" production of "new" influenza viruses. 3. Isolation of recombinant influenza viruses under simulated conditions of natural transmission. Virology 51: 149-162
57. Weigl JA, Puppe W, Schmitt HJ (2002) The incidence of influenza-associated hospitalizations in children in Germany. Epidemiol Infect 129: 525-533
58. Weingarten S, Riedinger M, Bolton LB, Miles P, Ault M (1989) Barriers to influenza vaccine acceptance. A survey of physicians and nurses. Am J Infect Control 17: 202-207
59. Woods M, Robke JT (2003) Removing hospitalization as a barrier to immunization. Clin Infect Dis 36: 673-674
60. Wright PF, Thompson J, Vaughn WK, Folland DS, Sell SH, Karzon DT (1977) Trials of influenza A/New Jersey/76 virus vaccine in normal children: an overview of age-related antigenicity and reactogenicity. J Infect Dis 136[Suppl]: S731-S741
61. Wright PF, Okabe N, McKee KT Jr, Maassab HF, Karzon DT (1982) Cold-adapted recombinant influenza A virus vaccines in seronegative young children. J Infect Dis 146: 71-79
62. Yassi A, Murdzak C, Cheang M, Tran N, Aoki FY (1994) Influenza immunization: knowledge, attitude and behaviour of health care workers. Can J Infect Control 9: 103-108
63. Zeiger RS (2002) Current issues with influenza vaccination in egg allergy. J Allergy Clin Immunol 110: 834-840
64. Zuccotti GV, Cucchi C, Sala D, Giovannini M (2002) Immunogenicity and safety of a virosomal influenza vaccine in HIV-infected children. Acta Paediatr 91: 486